Skip to content
10-Q

Quarterly Report

AETHLON MEDICAL INC AEMD

0001683168-25-006049

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Aug 13, 2025 2.6M sh
Shares Diluted Q1 2026 · Jun 30, 2025 2.08M sh
Shares Diluted restated Q1 2026 · Jun 30, 2024 932.25K sh
Operating Cash Flow Q1 2026 · Jun 30, 2025 −$1.71M
Operating Cash Flow Q1 2026 · Jun 30, 2024 −$1.75M
Cash And Equivalents Q1 2026 · Jun 30, 2025 $3.77M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $5.5M
Cash And Equivalents Q1 2026 · Jun 30, 2024 $9.07M
Stockholders Equity Q1 2026 · Jun 30, 2025 $3.42M
Stockholders Equity Q1 2026 · Mar 31, 2025 $5.12M
Stockholders Equity Q1 2026 · Jun 30, 2024 $8.71M
Stockholders Equity Q1 2026 · Mar 31, 2024 $5.77M
Current Liabilities Q1 2026 · Jun 30, 2025 $1.63M
Current Liabilities Q1 2026 · Mar 31, 2025 $1.9M
Total Liabilities Q1 2026 · Jun 30, 2025 $1.88M
Total Liabilities Q1 2026 · Mar 31, 2025 $2.24M
Current Assets Q1 2026 · Jun 30, 2025 $4.05M
Current Assets Q1 2026 · Mar 31, 2025 $5.95M
Total Assets Q1 2026 · Jun 30, 2025 $5.31M
Total Assets Q1 2026 · Mar 31, 2025 $7.36M
Eps Diluted Q1 2026 · Jun 30, 2025 −$0.85
Eps Diluted restated Q1 2026 · Jun 30, 2024 −$2.76
Eps Basic Q1 2026 · Jun 30, 2025 −$0.85
Eps Basic restated Q1 2026 · Jun 30, 2024 −$2.76
Sga Expense Q1 2026 · Jun 30, 2025 $735.36K
Sga Expense Q1 2026 · Jun 30, 2024 $751.97K
Rd Expense Q1 2026 · Jun 30, 2025 $524.37K
Rd Expense Q1 2026 · Jun 30, 2024 $414.66K
Net Income Q1 2026 · Jun 30, 2025 −$1.76M
Net Income Q1 2026 · Jun 30, 2024 −$2.57M
Operating Income Q1 2026 · Jun 30, 2025 −$1.79M
Operating Income Q1 2026 · Jun 30, 2024 −$2.62M